Others have used DNA alkylation to target MYCN gene amplification to reduce the number of MYCN copies, which resulted in decreased neuroblastoma proliferation in MYCN amplified, but not MYCN non-amplified, cells [51]. This evidence concerns the gene MYCN and neuroblastoma.